Trivalent Influenza virus vaccine(MDCK cell) (Sinovac Biotech)

三价流感病毒裂解疫苗（MDCK细胞）（北京科兴生物制品）

Report date: 2026/05/26 16:16:31

Base Information

Drug NameTrivalent Influenza virus vaccine(MDCK cell) (Sinovac Biotech)

Drug Alias NameN/A

ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSinovac Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A